Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$1.96 - $3.09 $174,639 - $275,325
-89,102 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.3 - $3.61 $30,410 - $47,731
-13,222 Reduced 12.92%
89,102 $244,000
Q4 2021

Feb 09, 2022

BUY
$3.09 - $4.81 $7,474 - $11,635
2,419 Added 2.42%
102,324 $336,000
Q3 2021

Nov 15, 2021

BUY
$3.17 - $4.39 $155,028 - $214,692
48,905 Added 95.89%
99,905 $387,000
Q2 2021

Aug 11, 2021

BUY
$3.02 - $5.21 $154,020 - $265,710
51,000 New
51,000 $197,000

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $170M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.